✦ LIBER ✦

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

✍ Scribed by C. Hicks; R. Wong; A. Manoharan; Y. L. Kwan

Publisher: Springer
Year: 2007
Tongue: English
Weight: 221 KB
Volume: 86
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-007-0297-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The number of CD34+ cells in peripheral

The number of CD34+ cells in peripheral blood as a predictor of the CD34+ yield in patients going to autologous stem cell transplantation

✍ A.L. Basquiera; P. Abichain; J.C. Damonte; B. Ricchi; A.G. Sturich; E.D. Palazzo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

The number of CD34+ cells in peripheral blood (PB) is a guide to the optimal timing to harvest peripheral blood progenitor cells (PBPC). The objective was to determine the number of CD34+ cells in PB that allows achieving a final apheresis product containing 1.5 • 10 6 CD34+ cells/kg, performing up

CXCR4 expression on transplanted periphe

CXCR4 expression on transplanted peripheral blood CD34+cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients

✍ Christine Hicks; Arend Isaacs; Rose Wong; Beng H. Chong 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 362 KB

Myeloma cell contamination of peripheral

Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

✍ Wichard Vogel; Hans-Georg Kopp; Lothar Kanz; Hermann Einsele 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 245 KB

Reduced dose of lenograstim is as effica

Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: A randomized study in patients undergoing autologous peripheral stem cell transplantation

✍ Selmin Ataergin; Fikret Arpaci; Mustafa Turan; Luis Solchaga; Turker Cetin; Must 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Efficacy of diverse high-dose regimens f

Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period

✍ P. S. Haas; K. Bauchmüller; A. Kühnemund; J. Finke; G. Ihorst; M. Engelhardt 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 89 KB

A Phase II study of 153Sm-EDTMP and high

A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Angela Dispenzieri; Gregory A. Wiseman; Martha Q. Lacy; Suzanne R. Hayman; Shaji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views